Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib and Ursodeoxycholic Acid for Duodenal Adenomas in FAP
NCT00808743Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2009
- Primary completion
- Jul 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ursodeoxycholic acid in Duodenal adenoma (DA), sponsored by Radboud University Medical Center. Started May 2009; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
Duodenal adenoma (DA)
Beyond the preview
Go deeper on NCT00808743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808743.